Autopsy report · NCT05028114
Tricaprilin Liquid Formulation PK Study
Cause of deathSlow enrollment
“Part 1 was completed, Part 2 and Part 3 of the study were not conducted under this study protocol due to subject recruitment difficulty.”
Life of this trial
- Ran for about 11 months before it stopped.
- 71 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Cerecin
- Sponsor type
- Industry
- Conditions
- Alzheimer Disease
- Interventions
- AC-1202; AC-OLE-01; AC-OLE-02; AC-OLE-03; AC-OLE-04; AC-OLE-05
- Participants
- 71
- Sites
- 1
- Countries
- Australia
Trials that died the same way
- Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
“The study was stopped due to recruitment difficulties” - Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants
“Subject recruitment and enrollment was low throughout the three years the study was active.” - Paracetamol With Caffeine to Treat Episodic Tension Type Headache
“Study was terminated due to unforeseen difficulties with subject recruitment. No safety issues were identified in the study with this new formulation.” - Comparing Palliative Radiotherapy With or Without Carboplatin
“The study was stopped due to insufficient recruitment.” - Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)
“Study was stopped due to insufficient recruitment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.